Overview

A Long-term Safety Study of Once-daily Travatan

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Travoprost